Implementing a Methadone Delivery System in New York City in Response to COVID-19

Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of public health (1971) 2021-12, Vol.111 (12), p.2115-2117
Hauptverfasser:	Harocopos, Alex, Nolan, Michelle L, Goldstein, Gail P, Mantha, Shivani, O'Neill, Madeleine, Paone, Denise
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Clinical medicine Collaboration Communicable Disease Control - organization & administration Comorbidity Coronaviruses COVID-19 COVID-19 - epidemiology Drug addiction Drugs Female Fentanyl Flexibility Health Service Delivery Hotels & motels Humans Illnesses Lockboxes Male Mental health Methadone Methadone - administration & dosage Methadone - therapeutic use Middle Aged Narcotics New York City - epidemiology Notes From the Field Opiate Substitution Treatment - methods Opinions, Ideas, & Practice Opioid-Related Disorders - drug therapy Opioids Overdose Pandemics Patients Program Evaluation Public health Quarantine Risk reduction SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Substance use disorder Telemedicine Telemedicine - organization & administration Toxicology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. ( . 2021;111(12):2115-2117. https://doi.org/10.2105/AJPH.2021.306523).
ISSN:	0090-0036 1541-0048
DOI:	10.2105/AJPH.2021.306523